Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Beatrice Totti"'
Autor:
Costanzo Padovano, Salvatore Daniele Bianco, Francesca Sansico, Elisabetta De Santis, Francesco Tamiro, Mattia Colucci, Beatrice Totti, Serena Di Iasio, Gaja Bruno, Patrizio Panelli, Giuseppe Miscio, Tommaso Mazza, Vincenzo Giambra
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-12 (2023)
Abstract Notch signaling is an evolutionary conserved pathway with a key role in tissue homeostasis, differentiation and proliferation. It was reported that Notch1 receptor negatively regulates mouse osteoclast development and formation by inhibiting
Externí odkaz:
https://doaj.org/article/4ff12c1df4a24a379f5bf3ce80c03f8a
Autor:
Emanuele Murgo, Elisabetta De Santis, Francesca Sansico, Valentina Melocchi, Tommaso Colangelo, Costanzo Padovano, Mattia Colucci, Annalucia Carbone, Beatrice Totti, Alireza Basti, Lisa Gottschlich, Angela Relogio, Nazzareno Capitanio, Fabrizio Bianchi, Gianluigi Mazzoccoli, Vincenzo Giambra
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 42, Iss 1, Pp 1-16 (2023)
Abstract Background T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive hematological malignancy, characterized by restricted cellular subsets with asymmetrically enriched leukemia initiating cell (LIC) activity. Nonetheless, it is still unc
Externí odkaz:
https://doaj.org/article/0fc5f0bade7443538b5545e035167ada
Autor:
Vincenzo Giambra, Danilo Pagliari, Pierluigi Rio, Beatrice Totti, Chiara Di Nunzio, Annalisa Bosi, Cristina Giaroni, Antonio Gasbarrini, Giovanni Gambassi, Rossella Cianci
Publikováno v:
Cells, Vol 12, Iss 22, p 2654 (2023)
Inflammatory bowel diseases (IBDs) are characterized by a persistent low-grade inflammation that leads to an increased risk of colorectal cancer (CRC) development. Several factors are implicated in this pathogenetic pathway, such as innate and adapti
Externí odkaz:
https://doaj.org/article/4b53fa385d324343974360caf5482c4a
Autor:
Rossella Cianci, Maria Grazia Massaro, Elisabetta De Santis, Beatrice Totti, Antonio Gasbarrini, Giovanni Gambassi, Vincenzo Giambra
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 19, p 14973 (2023)
Remdesivir (RDV) has demonstrated clinical benefit in hospitalized COronaVIrus Disease (COVID)-19 patients. The objective of this brief report was to assess a possible correlation between RDV therapy and the variation in lymphocyte subpopulations. We
Externí odkaz:
https://doaj.org/article/2062ff7bcd1246c1be682527054faddb
Autor:
Vincenzo Giambra, Annarita Valeria Piazzolla, Giovanna Cocomazzi, Maria Maddalena Squillante, Elisabetta De Santis, Beatrice Totti, Chiara Cavorsi, Francesco Giuliani, Nicola Serra, Alessandra Mangia
Publikováno v:
Vaccines, Vol 10, Iss 8, p 1281 (2022)
Background: LC has been associated with hyporesponsiveness to several vaccines. Nonetheless, no data on complete serological and B- and T-cell immune response are currently available. Aims: To assess, in comparison with healthy controls of the same a
Externí odkaz:
https://doaj.org/article/54827aff182a402fa9df69500f28593c
Autor:
Mattia Colucci, Elisabetta De Santis, Beatrice Totti, Mattia Miroballo, Francesco Tamiro, Giovanni Rossi, Ada Piepoli, Gabriella De Vincentis, Antonio Greco, Alessandra Mangia, Rossella Cianci, Lazzaro Di Mauro, Giuseppe Miscio, Vincenzo Giambra
Publikováno v:
Vaccines, Vol 9, Iss 10, p 1207 (2021)
The escalation of Coronavirus disease 2019 (COVID-19) has required the development of safe and effective vaccines against the severe acute respiratory syndrome coronavirus 2-associated (SARS-CoV-2), which is the causative agent of the disease. Here,
Externí odkaz:
https://doaj.org/article/2fe8929e566442de96b962cc06b0a3bf
Autor:
Lazzaro Di Mauro, Alessandra Mangia, Francesco Tamiro, Mattia Colucci, Rossella Cianci, Vincenzo Giambra, Giovanni Rossi, Antonio Greco, Mattia Miroballo, Gabriella De Vincentis, Giuseppe Miscio, Beatrice Totti, Ada Piepoli, Elisabetta De Santis
Publikováno v:
Vaccines, Vol 9, Iss 1207, p 1207 (2021)
Vaccines
Volume 9
Issue 10
Vaccines
Volume 9
Issue 10
The escalation of Coronavirus disease 2019 (COVID-19) has required the development of safe and effective vaccines against the severe acute respiratory syndrome coronavirus 2-associated (SARS-CoV-2), which is the causative agent of the disease. Here,